BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China
I'm PortAI, I can summarize articles.
BGI Genomics and Roche Diagnostics have launched Alzheimer's diagnostic tests in China to improve access to easier diagnosis and monitoring. BGI's blood test is being used in several cities to assess disease progression, while Roche is working on a test for pTau181 in Boao. These blood tests aim to expedite diagnosis and facilitate access to treatments, contrasting with traditional methods like spinal taps and PET scans. Both companies emphasize that their tests are not standalone diagnostic tools but can aid in early screening and reduce unnecessary investigations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments